Microbiology News and Research

RSS

Hybrid virus infects cells, interacts with antibodies just like COVID-19 virus

Airborne and potentially deadly, the virus that causes COVID-19 can only be studied safely under high-level biosafety conditions.

22 Jul 2020

Study shows flotillin proteins have direct influence on cell membrane structure

Similar to all cells, bacteria have a membrane that protects them from the outside just like skin.

20 Jul 2020

Scientists gain insights into how parasitic bacterium gives rise to lesions

Bacteria of the genus Bartonella are parasites that can be transmitted to humans via insect bites and animal scratches, resulting in an infection known as "bartonellosis." Cat-scratch disease and trench fever are forms of bartonellosis caused by different Bartonella species infecting humans.

17 Jul 2020

Study uncovers virus-specific T cell immunity in recovered COVID-19 and SARS patients

The T cells, along with antibodies, are an integral part of the human immune response against viral infections due to their ability to directly target and kill infected cells.

17 Jul 2020

Microbiologists identify bacteria which feed on manganese

Caltech microbiologists have discovered bacteria that feed on manganese and use the metal as their source of calories. Such microbes were predicted to exist over a century ago, but none had been found or described until now.

16 Jul 2020

Combination of western-style high-fat diet with antibiotic can increase the risk of pre-IBD

Researchers have found that combining a Western-style high-fat diet with antibiotic use significantly increases the risk of developing pre- inflammatory bowel disease.

16 Jul 2020

Healthy microbiome can reduce severity of chickungunya disease

Chikungunya virus, once confined to the Eastern Hemisphere, has infected millions of people in the Americas since 2013, when mosquitoes carrying the virus were discovered in the Caribbean.

15 Jul 2020

Investigational COVID-19 vaccine is safe, generates neutralizing antibody activity in healthy adults

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine.

15 Jul 2020

Early exposure to vaccine-derived antigens can have dramatic effect on antibody diversity

University of Alabama at Birmingham researchers have added fresh evidence that early exposure to vaccine-, bacterial- or microbiota-derived antigens has a dramatic effect on the diversity of antibodies an adult mammal will have to fight future infections by pathogens.

14 Jul 2020

Severely injured donor lungs can be recovered using cross-circulation platform

Respiratory disease is the third leading cause of death worldwide, and lung transplantation is still the only cure for patients with end-stage lung disease.

14 Jul 2020

Common molecular feature in SARS-CoV-2 neutralizing antibodies discovered

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

14 Jul 2020

Scientists discover new antiviral drug against paramyxovirus

A new antiviral drug that is effective against a broad range of human pathogens in the paramyxovirus family, such as the human parainfluenzaviruses and measles virus, has been discovered by researchers in the Institute for Biomedical Sciences at Georgia State University.

14 Jul 2020

Altimmune reports positive results on intranasal COVID-19 vaccine candidate

Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.

14 Jul 2020

New mutation in common flu subtype helps evade immune response

Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

13 Jul 2020

New type of molecular editor can make precise changes in mitochondrial DNA

The genome in mitochondria -- the cell's energy-producing organelles -- is involved in disease and key biological functions, and the ability to precisely alter this DNA would allow scientists to learn more about the effects of these genes and mutations.

9 Jul 2020

Researchers discover how good gut bacteria can help reduce heart disease risk

Scientists have discovered that one of the good bacteria found in the human gut has a benefit that has remained unrecognized until now: the potential to reduce the risk for heart disease.

9 Jul 2020

Researchers identify protective antibodies for rare, polio-like disease in children

Researchers at Vanderbilt University Medical Center, Purdue University and the University of Wisconsin-Madison have isolated human monoclonal antibodies that potentially can prevent a rare but devastating polio-like illness in children linked to a respiratory viral infection.

6 Jul 2020

Long-term culture of human pancreatic slices as a model to study regeneration of beta cells

Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have developed a method allowing for the long-term culture of "pancreatic slices" to study the regeneration of the human pancreas in real time.

2 Jul 2020

Wild strains of salmonella find a backdoor entry into plants

As the world wrestles with the coronavirus (COVID-19) pandemic, which arose after the virus jumped from an animal species to the human species, University of Delaware researchers are learning about new ways other pathogens are jumping from plants to people.

1 Jul 2020

Study provides roadmap for developing effective vaccine against Staphylococcal infections

Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments.

1 Jul 2020

Microbiology News and Research

Hybrid virus infects cells, interacts with antibodies just like COVID-19 virus

Study shows flotillin proteins have direct influence on cell membrane structure

Scientists gain insights into how parasitic bacterium gives rise to lesions

Study uncovers virus-specific T cell immunity in recovered COVID-19 and SARS patients

Microbiologists identify bacteria which feed on manganese

Combination of western-style high-fat diet with antibiotic can increase the risk of pre-IBD

Healthy microbiome can reduce severity of chickungunya disease

Investigational COVID-19 vaccine is safe, generates neutralizing antibody activity in healthy adults

Early exposure to vaccine-derived antigens can have dramatic effect on antibody diversity

Severely injured donor lungs can be recovered using cross-circulation platform

Common molecular feature in SARS-CoV-2 neutralizing antibodies discovered

Scientists discover new antiviral drug against paramyxovirus

Altimmune reports positive results on intranasal COVID-19 vaccine candidate

New mutation in common flu subtype helps evade immune response

New type of molecular editor can make precise changes in mitochondrial DNA

Researchers discover how good gut bacteria can help reduce heart disease risk

Researchers identify protective antibodies for rare, polio-like disease in children

Long-term culture of human pancreatic slices as a model to study regeneration of beta cells

Wild strains of salmonella find a backdoor entry into plants

Study provides roadmap for developing effective vaccine against Staphylococcal infections

Colony Picking eBook: Using Automation to Implement Colony Picking Workflows eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics